ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NIVIA HERNANDEZ RAMOS M.D.

Neurology

1,087

$94.6K

185
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 34%

$87
Average prescription price

Avg: $113

DESIREE CASASNOVAS - LOPEZ M.D.

Neurology

1,035

$98.9K

133
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 34%

$96
Average prescription price

Avg: $113

DIANA BALSALOBRE M.D.

Neurology

994

$143K

121
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 34%

$143
Average prescription price

Avg: $113

WILLIAM PHILIPPI MD

Neurology

958

$90.2K

140
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 34%

$94
Average prescription price

Avg: $113

CARMEN SERRANO M.D.

Neurology

918

$71.4K

92
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 34%

$78
Average prescription price

Avg: $113

RENATO SARTORI MD

Neurology

915

$66.6K

142
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 34%

$73
Average prescription price

Avg: $113

MELISSA MENDEZ MORALES M.D.

Neurology

890

$44.5K

94
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 34%

$50
Average prescription price

Avg: $113

DALILA NATALI M.D,

Neurology

862

$57.2K

172
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 34%

$66
Average prescription price

Avg: $113

RAUL CRUZ MD

Neurology

832

$297K

43
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 34%

$357
Average prescription price

Avg: $113

JUAN RODRIGUEZ DEL VALLE MD

Neurology

793

$106K

109
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 34%

$134
Average prescription price

Avg: $113

OSCAR BENITEZ MD

Neurology

743

$64.7K

120
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 34%

$87
Average prescription price

Avg: $113

REYNALDO RODRIGUEZ-LLAUGER M.D.

Neurology

731

$63.1K

71
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 34%

$86
Average prescription price

Avg: $113

KATHERINE PADILLA-RODRIGUEZ M.D.

Neurology

672

$62.8K

131
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 34%

$93
Average prescription price

Avg: $113

OLGA RIOS M.D.

Neurology

584

$30.2K

86
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 34%

$52
Average prescription price

Avg: $113

ENRICO SARTORI MD

Neurology

575

$56.7K

109
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 34%

$99
Average prescription price

Avg: $113

MONSERRATE NORIEGA-SANCHEZ M.D

Neurology

538

$71.9K

64
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 34%

$134
Average prescription price

Avg: $113

LUDEMAR ROMAN ACOSTA M.D

Neurology

509

$30.2K

86
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 34%

$59
Average prescription price

Avg: $113

JULIO CALCANO M.D.

Neurology

501

$25.7K

124
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 34%

$51
Average prescription price

Avg: $113

MAYRA VERA-RAMIREZ M.D.

Neurology

381

$34.2K

66
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 34%

$90
Average prescription price

Avg: $113

CARLOS LUCIANO-ROMAN M.D.

Neurology

379

$28.1K

58
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 34%

$74
Average prescription price

Avg: $113

FRANCES VELEZ LAGO M.D.

Neurology

296

$23.6K

57
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 34%

$80
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank